Skip to main content
TipRanks
Go Ultimate75% OFF

Ligand Pharma (LGND) Revenue

860 Followers

Ligand Pharma Revenue

Ligand Pharma had a revenue of 78.75M in the quarter ending Sep 30, 2026, with 23.63%. This bring the company's revenue in the last twelve months to 253.83M, Decreased 12.64%. In the fiscal year ending Dec 31, 2025, Ligand Pharma had annual revenue of 268.09M with 60.40% growth.

Revenue (ttm)
253.83M
Revenue Growth
1.03%
P/S Ratio
23.04
Revenue/Employee
$5,703,979
Employees
47
Market Cap
$6.18B

Revenue Chart

Ligand Pharma Revenue - Annual

050M100M150M200M250M300M141.10M251.45M120.28M163.56M241.54M196.25M131.31M167.13M268.09M201720182019202020212022202320242025
Revenue History
Download to Excel
LGND revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025268.09M100.95M60.40%
Dec 31, 2024167.13M35.82M27.28%
Dec 31, 2023131.31M-64.93M-33.09%
Dec 31, 2022196.25M-45.30M-18.75%
Dec 31, 2021241.54M77.98M47.68%
Dec 31, 2020163.56M43.28M35.98%
Dec 31, 2019120.28M-131.17M-52.17%
Dec 31, 2018251.45M110.35M78.21%
Dec 31, 2017141.10M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
LGND253.83M
ARWR450.82M
IONS959.76M
XNCR200.49M
ZYME265.97M
ABCL67.86M